Geriatric Medicines Global Market Report 2025

Description

Geriatric medicines are medications specifically prescribed for individuals aged 65 and older, addressing their unique health needs. These medications are formulated to support cognitive function, mobility, and immune health while taking into account the physiological changes that impact drug metabolism in older adults. They are commonly used to manage chronic conditions and age-related symptoms, ultimately enhancing the overall quality of life for the elderly.

The main therapeutics used in geriatric medicines include analgesics, antihypertensives, statins, proton pump inhibitors, anticoagulants, antipsychotics, and others. Analgesics are essential in geriatric care to manage chronic pain, improve mobility, and enhance the quality of life. These medications are applied in various conditions such as cardiovascular disease, arthritis, neurological disorders, cancer, osteoporosis, and respiratory issues, among others. They are administered through different routes, including oral, parenteral, and others, and are distributed through various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.

The geriatric medicines market research report is one of a series of new reports from The Business Research Company that provides geriatric medicines market statistics, including the geriatric medicines industry global market size, regional shares, competitors with the geriatric medicines market share, detailed geriatric medicines market segments, market trends, and opportunities, and any further data you may need to thrive in the geriatric medicines industry. These geriatric medicines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The geriatric medicines market size has grown rapidly in recent years. It will grow from $1,227.91 billion in 2024 to $1,430.84 billion in 2025 at a compound annual growth rate (CAGR) of 16.5%. The growth observed during the historic period can be attributed to factors such as the increasing prevalence of stroke, the rising incidence of chronic diseases, a growing prevalence of cardiovascular diseases, increased government support, and a heightened emphasis on personalized medicine.

The geriatric medicines market size is expected to see rapid growth in the next few years. It will grow to $2,604.86 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth projected for the forecast period can be attributed to factors such as the increasing prevalence of age-related health conditions, a growing geriatric population, rising healthcare expenditures, the expansion of geriatric medicine, and a higher incidence of hypertension. Key trends expected during this period include the use of digital pills and wearable health devices, the development of tools and strategies to manage multiple medications safely, advancements in stem cell and gene therapy, the expanded use of telehealth platforms, and innovations in early diagnosis and prevention of age-related diseases.

The growth of the geriatric medicines market is expected to be driven by the rising prevalence of age-related health conditions. These conditions become more common or severe with aging, largely due to the natural aging process. Factors such as increased life expectancy, advancements in healthcare, and a growing elderly population contribute to the higher occurrence of these health issues. Geriatric medicines are crucial in managing these age-related conditions, offering specialized treatments that enhance the quality of life and healthcare outcomes for older individuals. For example, a report by the Office for Health Improvement and Disparities (OHID) in March 2023 revealed that 17.6% of individuals aged 16 and older in the UK reported having a long-term musculoskeletal (MSK) condition, such as arthritis or chronic joint problems, in 2022. This represents an increase from 17.0% in 2021. Consequently, the rising prevalence of age-related health conditions is propelling the growth of the geriatric medicines market.

Leading companies in the geriatric medicines market are focusing on developing innovative diabetes therapies to meet the growing demand for effective treatments in the aging population. Diabetes therapy involves cutting-edge treatments that improve management or offer potential cures, aiming to surpass traditional methods in terms of safety, efficacy, and patient outcomes. For example, in August 2023, Akums Drugs & Pharmaceuticals Ltd., a pharmaceutical company based in India, introduced a novel combination therapy of Vildagliptin SR and Metformin SR. This new formulation is designed specifically to manage Type 2 diabetes in elderly patients, offering improved glycemic control while addressing key concerns such as hypoglycemia and weight gain, which are especially important for this group. The combination works by enhancing insulin secretion and lowering blood sugar levels, providing both safety and effectiveness. The product has been approved by the Drug Controller General of India (DCGI).

In October 2023, Zydus Pharmaceuticals UK Limited, a pharmaceutical company based in the UK, acquired LiqMeds Group for an undisclosed sum. This acquisition is intended to strengthen Zydus Life Sciences' position in the expanding oral liquid products market, addressing the specific needs of geriatric and pediatric patients. LiqMeds Group, also based in the UK, specializes in oral liquid formulations, which are particularly advantageous for elderly patients.

Major players in the geriatric medicines market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Macleods Pharmaceuticals Ltd., Apotex Inc., Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., and Endo Pharmaceuticals Inc.

North America was the largest region in the geriatric medicines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in geriatric medicines report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the geriatric medicines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The geriatric medicines market consists of sales of antidepressants, diuretics, antidiabetics, and anticonvulsants. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Geriatric Medicines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on geriatric medicines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for geriatric medicines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The geriatric medicines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapeutics: Analgesics; Antihypertensive; Statins; Proton Pump Inhibitors; Anticoagulant; Antipsychotic; Other Therapeutics
2) By Condition: Cardiovascular; Arthritis; Neurological; Cancer; Osteoporosis; Respiratory; Other Conditions
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Analgesics: Non-Opioid Analgesics (Acetaminophen, NSAIDs); Opioid Analgesics (Morphine, Oxycodone); Topical Analgesics (Lidocaine Patches)
2) By Antihypertensive: Angiotensin-Converting Enzyme (ACE) Inhibitors; Angiotensin II Receptor Blockers (ARBs); Beta-Blockers; Calcium Channel Blockers; Diuretics; Alpha-Blockers
3) By Statins: Atorvastatin; Simvastatin; Rosuvastatin; Pravastatin; Lovastatin
4) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole; Rabeprazole
5) By Anticoagulant: Warfarin; Direct Oral Anticoagulants (DOACs): Dabigatran, Rivaroxaban, Apixaban; Heparin
6) By Antipsychotic: Atypical Antipsychotics; Typical Antipsychotics
7) By Other Therapeutics: Antidepressants (SSRIs, SNRIs); Antidiabetic Medications (Insulin, Metformin); Anticonvulsants; Anti-Inflammatory Drugs (Corticosteroids); Cognitive Enhancers (Donepezil, Memantine)
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33747

1. Executive Summary

2. Geriatric Medicines Market Characteristics

3. Geriatric Medicines Market Trends And Strategies

4. Geriatric Medicines Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Geriatric Medicines Growth Analysis And Strategic Analysis Framework

5.1. Global Geriatric Medicines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Geriatric Medicines Market Growth Rate Analysis
5.4. Global Geriatric Medicines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Geriatric Medicines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Geriatric Medicines Total Addressable Market (TAM)

6. Geriatric Medicines Market Segmentation

6.1. Global Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Analgesics
Antihypertensive
Statins
Proton Pump Inhibitors
Anticoagulant
Antipsychotic
Other Therapeutics
6.2. Global Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Other Conditions
6.3. Global Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Routes Of Administration
6.4. Global Geriatric Medicines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Geriatric Medicines Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Opioid Analgesics (Acetaminophen, NSAIDs)
Opioid Analgesics (Morphine, Oxycodone)
Topical Analgesics (Lidocaine Patches)
6.6. Global Geriatric Medicines Market, Sub-Segmentation Of Antihypertensive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Angiotensin-Converting Enzyme (ACE) Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Beta-Blockers
Calcium Channel Blockers
Diuretics
Alpha-Blockers
6.7. Global Geriatric Medicines Market, Sub-Segmentation Of Statins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atorvastatin
Simvastatin
Rosuvastatin
Pravastatin
Lovastatin
6.8. Global Geriatric Medicines Market, Sub-Segmentation Of Proton Pump Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Omeprazole
Esomeprazole
Lansoprazole
Pantoprazole
Rabeprazole
6.9. Global Geriatric Medicines Market, Sub-Segmentation Of Anticoagulant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Warfarin
Direct Oral Anticoagulants (DOACs): Dabigatran, Rivaroxaban, Apixaban
Heparin
6.10. Global Geriatric Medicines Market, Sub-Segmentation Of Antipsychotic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atypical Antipsychotics
Typical Antipsychotics
6.11. Global Geriatric Medicines Market, Sub-Segmentation Of Other Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antidepressants (SSRIs, SNRIs)
Antidiabetic Medications (Insulin, Metformin)
Anticonvulsants
Anti-Inflammatory Drugs (Corticosteroids)
Cognitive Enhancers (Donepezil, Memantine)

7. Geriatric Medicines Market Regional And Country Analysis

7.1. Global Geriatric Medicines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Geriatric Medicines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Geriatric Medicines Market

8.1. Asia-Pacific Geriatric Medicines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Geriatric Medicines Market

9.1. China Geriatric Medicines Market Overview
9.2. China Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Geriatric Medicines Market

10.1. India Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Geriatric Medicines Market

11.1. Japan Geriatric Medicines Market Overview
11.2. Japan Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Geriatric Medicines Market

12.1. Australia Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Geriatric Medicines Market

13.1. Indonesia Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Geriatric Medicines Market

14.1. South Korea Geriatric Medicines Market Overview
14.2. South Korea Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Geriatric Medicines Market

15.1. Western Europe Geriatric Medicines Market Overview
15.2. Western Europe Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Geriatric Medicines Market

16.1. UK Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Geriatric Medicines Market

17.1. Germany Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Geriatric Medicines Market

18.1. France Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Geriatric Medicines Market

19.1. Italy Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Geriatric Medicines Market

20.1. Spain Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Geriatric Medicines Market

21.1. Eastern Europe Geriatric Medicines Market Overview
21.2. Eastern Europe Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Geriatric Medicines Market

22.1. Russia Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Geriatric Medicines Market

23.1. North America Geriatric Medicines Market Overview
23.2. North America Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Geriatric Medicines Market

24.1. USA Geriatric Medicines Market Overview
24.2. USA Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Geriatric Medicines Market

25.1. Canada Geriatric Medicines Market Overview
25.2. Canada Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Geriatric Medicines Market

26.1. South America Geriatric Medicines Market Overview
26.2. South America Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Geriatric Medicines Market

27.1. Brazil Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Geriatric Medicines Market

28.1. Middle East Geriatric Medicines Market Overview
28.2. Middle East Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Geriatric Medicines Market

29.1. Africa Geriatric Medicines Market Overview
29.2. Africa Geriatric Medicines Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Geriatric Medicines Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Geriatric Medicines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Geriatric Medicines Market Competitive Landscape And Company Profiles

30.1. Geriatric Medicines Market Competitive Landscape
30.2. Geriatric Medicines Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Geriatric Medicines Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. F. Hoffmann-La Roche AG
31.3. GlaxoSmithKline plc
31.4. Eli Lilly and Company
31.5. Viatris Inc.
31.6. Teva Pharmaceutical Industries Ltd.
31.7. Boehringer Ingelheim GmbH
31.8. Regeneron Pharmaceuticals Inc.
31.9. Macleods Pharmaceuticals Ltd.
31.10. Apotex Inc.
31.11. Intas Pharmaceuticals Limited
31.12. Dr. Reddy's Laboratories
31.13. Lupin Limited
31.14. Biocon Limited
31.15. Torrent Pharmaceuticals Ltd.

32. Global Geriatric Medicines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Geriatric Medicines Market

34. Recent Developments In The Geriatric Medicines Market

35. Geriatric Medicines Market High Potential Countries, Segments and Strategies

35.1 Geriatric Medicines Market In 2029 - Countries Offering Most New Opportunities
35.2 Geriatric Medicines Market In 2029 - Segments Offering Most New Opportunities
35.3 Geriatric Medicines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer